Open AccessDesign of two immunotoxins based rovalpituzumab antibody against DLL3 receptor; a promising potential opportunity
Author(s) -
Mohammad Hossein Ataee,
Seyed Ali Mirhosseini,
Reza Mirnejad,
Ehsan Rezaie,
Hamideh Mahmoodzadeh Hosseini,
Jafar Amani
Publication year - 2022
Publication title -
research in pharmaceutical sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.685
H-Index - 29
eISSN - 1735-9414
pISSN - 1735-5362
DOI - 10.4103/1735-5362.350243
Subject(s) - immunotoxin , chemistry , recombinant dna , microbiology and biotechnology , docking (animal) , cancer research , biochemistry , biology , cytotoxicity , gene , in vitro , medicine , nursing
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom